Clinical Trial Update: Onyx™ Liquid Embolic IDE Clinical Study [NA]

View source ↗

Summary

An IDE clinical study evaluating Onyx Liquid Embolic by Medtronic Endovascular for hemorrhage-related conditions is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Bleeding
• Peptic Ulcer Disease

Drugs mentioned

• Onyx Liquid Embolic (Ethylene vinyl alcohol copolymer (EVOH)-based liquid embolic agent)

Snippet

Sponsor: Medtronic Endovascular | Conditions: Peripheral Arterial Hemorrhage, Trauma | NA | Status: RECRUITING